Metals and Neurological Disorders: Exploring Neurotoxicity Mechanisms and Receptor Targets

Neurological disorders encompass a diverse group of conditions that affect the brain, spinal cord, and peripheral nerves. Their pathophysiology is multifactorial, involving genetic mutations, infections, trauma, autoimmune responses, and exposure to environmental toxins. Central to many of these disorders are pathological mechanisms such as neurodegeneration, synaptic dysfunction, neuroinflammation, and abnormal protein aggregation. Increasing evidence highlights the critical role of metal homeostasis, both of essential and toxic metals, in neurological health and disease. Essential metals, such as iron, zinc, copper, and magnesium are crucial for cellular metabolism, neurotransmission, and antioxidant defence. However, their dysregulation, whether through deficiency or overload, can induce oxidative stress and contribute to neurodegenerative processes. Conversely, toxic metals like lead, mercury, cadmium, arsenic, and aluminium pose serious threats to neuronal integrity by mimicking essential metals, disrupting enzymatic function, and triggering inflammation and apoptosis. This chapter explores how the dualistic roles of metals modulate key cellular pathways and influence the onset and progression of neurological diseases. A deeper understanding of metal-mediated neuropathology may offer promising avenues for biomarker discovery and therapeutic intervention.

Metal homeostasis is essential for maintaining physiological balance and ensuring proper cellular function in the human body. Essential metals such as iron, zinc, copper, calcium, and magnesium play pivotal roles in enzymatic activity, neurotransmission, gene expression, and antioxidant defense. However, even slight disturbances in their regulation can trigger pathological processes, including oxidative stress, mitochondrial dysfunction, and inflammation. The body maintains metal homeostasis through a finely tuned network of transporters, storage proteins, and regulatory pathways that control absorption, distribution, and excretion. Disruption of these mechanisms due to genetic factors, environmental exposure, or disease can lead to serious health outcomes, particularly neurodegenerative disorders. Understanding the intricate mechanisms of metal uptake, trafficking, and cellular compartmentalization is vital for developing targeted diagnostics and therapies. This section delves into the molecular pathways of metal regulation and highlights their significance in health and disease, offering insights into how restoring homeostasis may serve as a therapeutic strategy against metal-induced pathologies. 

Environmental pollution from industrial, agricultural, and nutritional sources causes metal poisoning, which is a serious health risk to humans. With an emphasis on their effects on biological systems, this overview examines the several ways that metals may enter the body, such as through the air, water, soil, and food. While hazardous metals like lead, mercury, arsenic, and cadmium disturb cellular homeostasis and result in oxidative stress, neurotoxicity, and organ destruction, essential metals like copper and zinc are essential for physiological processes. Contamination of packaged food and water increases exposure risks and can result in long-term health issues like cancer, heart disease, and developmental abnormalities. Developing preventative measures requires an understanding of the processes behind metal toxicity, such as bioaccumulation, enzyme inhibition, and DNA damage. In order to mitigate metal pollution, this chapter emphasizes the importance of industrial waste management, regulatory frameworks, and bioremediation strategies. To lessen human exposure, better packing materials and environmentally friendly farming methods are also advised. To protect the public from the harmful consequences of metal toxicity, a thorough, interdisciplinary strategy that combines technical innovation, regulatory enforcement, and public awareness is necessary. 

Healthcare outcomes heavily depend on epidemiological methods because they enable people to understand disease causes and distributions, as well as disease mechanisms. The research conducted in laboratories simultaneously runs clinical trials to study disease patterns and identify risks before confirming the safety and effectiveness of medications. Human health heavily depends on the regulation of essential metals, including iron, zinc, copper, and manganese, because improper levels can lead to serious medical problems. Neuroprotective mechanisms are activated in response to metabolic disturbances, leading to key events that cause cell death. Iron deficiency anemia, hemochromatosis, Wilson's disease, and Menkes disease are all inherited conditions that are exclusively caused by imbalances in body metals. As a result of factors such as genetics, environmental factors, and dietary habits, the prevalence rates of these illnesses vary among metal groups and regions. The severe health challenges caused by heavy metal toxins like lead, mercury, and cadmium affect multiple organs during prenatal growth and infancy because they appear in both industrial areas and natural environments. When coupled with inadequate sanitation and restricted medical access, these health issues are effectively addressed by the combination of drug-resistant parasitic diseases. In laboratories, the integration of mass spectrometry and atomic absorption spectrometry enables health professionals to detect metal imbalances, which in turn empowers physicians to prescribe specific medical treatments. International partnerships are necessary to resolve the security concerns of health security initiatives at the global level, as they are designed to prevent health disparities arising from parasitic infections and metal imbalance.

A global health risk that affects millions of people globally is environmental exposure to neurotoxic metals and metalloids, including arsenic, cadmium, lead, mercury, and manganese. Environmental metals can alter neurodevelopment, neurobehavior, and cognition, as well as induce neurodegeneration, depending on the lifetime exposure duration. Bioaccumulation of these heavy metals leads to a diversity of harmful effects on a number of bodily tissues and organs. Growth, proliferation, differentiation, damage-repairing mechanisms, and apoptosis are among the biological processes that heavy metals interfere with. A comparison of the mechanisms of action shows that these metals can cause toxicity through comparable pathways, such as the production of ROS, oxidative stress, enzyme inactivation, and weakened antioxidant defence. As the brain consumes a substantial amount of energy, mitochondrial malfunction and the resultant drop in levels of ATP may dramatically affect brain function, resulting in neuronal cell death and associated neurological diseases. Multiple astroglial pathway deficiencies can even cause neurodegeneration. Heavy metal consumption affects the glutamate/GABA-glutamine shuttle, antioxidant machinery, and energy metabolism, among other astroglial homeostatic and neuroprotective cascades. Long-term exposure to heavy metals can cause chronic neuroinflammation, which releases inflammatory mediators and activates immune cells. This can cause damage to neurons, and cognitive impairment leads to neuronal dysfunction. Toxicity analysis of heavy metals can be done by in vivo and in vitro methods, followed by animal testing and different assays to check the viability of cells, such as MTT, Comet assay, etc.

Attention deficit disorder (ADD) is a neurodevelopmental disorder with a multicausative etiology, such as genetic, environmental, and biological factors, characterized by inattention, impulsivity, and hyperactivity symptoms. Among novel environmental factors, exposure to metals has raised great concern due to their implication in neurotoxicity and mental impairment. Heavy metals such as lead (Pb), mercury (Hg), cadmium (Cd), and arsenic (As) are involved in oxidative stress, neuroinflammation, and neurotransmitter dysregulation that play roles in the pathophysiology of ADD. However, the essential metals iron (Fe), zinc (Zn), magnesium (Mg), and copper (Cu) play critical roles in neurodevelopment, and their deficit or imbalance poses a potential risk of exacerbating the symptoms of ADD. The mechanistic processes through which metals impact brain function, including oxidative injury, disruption of dopaminergic and glutamatergic signaling, and epigenetic modifications, are the topic of this chapter. The etiology of metal exposure, ranging from environmental contaminants in air, water, and food to prenatal and neonatal exposure, is debated to highlight key determinants of risk. Furthermore, diagnostic procedures, including biomarker detection and neuroimaging to quantify metal accumulation in ADD subjects, are considered. Interventions such as dietary modification, chelation therapy, and behavioral approaches are also considered, along with future directions in personalized medicine and public health interventions for metal-induced neurotoxicity prevention. Understanding the intricate interaction between metals and ADD can result in targeted therapeutic approaches and policy measures for reducing the risk of environmental exposure.

Aluminium is an extensively dispersed environmental metal with important implications for human health. The exposure to aluminium is via various routes, viz., ingestion from contaminated food, water, and drugs, inhalation in occupational and environmental contexts, and skin contact. Prenatal exposure also evokes concern about developmental toxicity. The uptake of aluminium is mainly via the gastrointestinal tract, respiratory system, and skin, with systemic bioavailability being a function of chemical speciation and physiological considerations. The excretion routes are urinary and fecal elimination, with minor contributions from sweat and skin desquamation. Aluminium is increasingly involved in the pathogenesis of numerous neurological disorders. Its neurotoxicity is linked to oxidative stress, neuroinflammation, mitochondrial dysfunction, and metal homeostasis disruption, leading to the development and progression of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Huntington's disease. Aluminium toxicity detection requires sophisticated analytical methods, including neuroimaging techniques. Strategies in mitigation include both pharmacological measures, i.e., chelating compounds and antioxidants, and non-pharmacological measures, i.e., dietary changes and environmental control. Future studies need to identify new biomarkers of aluminium neurotoxicity and refine more sensitive neuroimaging modalities to monitor aluminium deposition in the brain. Knowledge of the long-term effects of aluminium exposure is important for developing preventive and therapeutic interventions. With its prevalence and possible neurotoxicity, ongoing research on aluminium toxicology is still important for public health and regulatory issues.

Lead (Pb) is a neurotoxic heavy metal that poses several risks to human neurological health through exposure for a long period at low concentrations. Its ability to cross the blood-brain barrier (BBB) facilitates lead-induced neurodegeneration via several mechanisms, such as amyloid-β (Aβ) plaque deposition, tau hyperphosphorylation, degeneration of dopaminergic neurons, and loss of synaptic plasticity. They result from interconnected processes: oxidative stress, mitochondrial dysfunction, disruption of calcium signaling, and epigenetic dysregulation. These processes drive neurodegeneration in Alzheimer's disease (AD) through Aβ/NFT deposition, Parkinson's disease (PD) through α-synuclein aggregation and dopamine loss, multiple sclerosis through immune dysregulation and BBB disruption, and Amyotrophic Lateral Sclerosis (ALS) through motor neuron apoptosis. Furthermore, lead exposure exacerbates this condition by disrupting copper homeostasis, microRNA networks, and glial activation, worsening neuroinflammation and protein misfolding. Therefore, different detection strategies, such as blood lead level (BLL) screening, Xray fluorescence (XRF) for bone lead measurement, and inductively coupled plasma mass spectrometry (ICP-MS) for trace analysis of Pb, are essential for early intervention and prevention of its accumulation. This book chapter discusses the detailed mechanisms of lead-induced toxicity, along with different detection techniques to detect lead-induced neurological damage, which provides vital information to reduce its burden in neurodegenerative disorders.

Iron is a crucial nutrient essential for the optimal functioning of the central nervous system (CNS). It plays a vital role in oxygen transport, energy metabolism, and neurotransmitter synthesis. An imbalance in iron levels, whether deficiency or excess, can disrupt iron homeostasis, leading to oxidative stress, inflammation, and protein aggregation. Such disruptions are linked to several neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). Excess iron accumulation can interfere with the Fenton reaction, generating oxidative stress and contributing to mitochondrial dysfunction. In Parkinson’s disease, iron deposits contribute to the formation of Lewy bodies, a key pathological feature of the condition. Additionally, iron overload is associated with tau hyperphosphorylation, leading to neurofibrillary tangles commonly found in Alzheimer’s disease. Moreover, excessive iron levels contribute to demyelination and motor neuron degeneration, accelerating the progression of neurodegenerative disorders. Advancements in medical technology have enhanced the ability to detect iron accumulation in the brain. Diagnostic techniques include X-ray imaging, MRI-based methods, transcranial sonography, and cerebrospinal fluid analysis. Several iron-chelating agents, such as deferoxamine, deferasirox, and deferiprone, are available for therapeutic use to counteract iron toxicity. A deeper understanding of iron’s involvement in neurodegeneration can lead to developing novel therapeutic strategies to slow or prevent disease progression. This chapter explores the role of iron in CNS function, the consequences of iron dysregulation, available detection methods, and potential treatment approaches for iron-related neurodegenerative disorders. 

This chapter explores the intricate role of genetic variations and oxidative stress pathways in the etiology and progression of neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD). It highlights how genetic mutations in key genes like APP, PSEN1, PSEN2, SNCA, LRRK2, PRKN, and PINK1 are linked to familial forms of these disorders, while environmental and epigenetic factors also contribute significantly. Metal-induced neurotoxicity in brain regions such as the hippocampus and basal ganglia, triggered by elements like lead, manganese, and iron, is discussed in depth. The chapter emphasizes the impact of metal transport genes (HFE, SLC40A1, and ATP13A2) and detoxification enzymes such as glutathione S-transferases (GSTs) and metallothioneins (MTs) in mitigating oxidative damage. Special focus is given to antioxidant defense pathways involving superoxide dismutase (SOD) and catalase (CAT), detailing their biochemical mechanisms and regulatory functions. Dysfunction in these enzymes due to genetic mutations, oxidative overload, or aging correlates strongly with increased vulnerability to neuronal damage and disease progression. By integrating molecular genetics, toxicology, and enzymology, the chapter underscores the significance of maintaining redox homeostasis and suggests therapeutic potential in targeting antioxidant pathways for managing neurodegenerative conditions.

Early detection of metal-induced neurotoxicity is critical for preventing and managing neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington's disease. These sections highlight the growing importance of diagnostic and therapeutic strategies centred on metal-related biomarkers. Advances in molecular biology and neuroimaging have enabled the identification of specific biomarkers, such as metal-binding proteins, metalloproteins, and oxidative stress indicators, that reflect the early pathological changes. These biomarkers offer promising tools for noninvasive diagnosis, disease staging, and therapeutic monitoring. Emerging imaging modalities and biosensor technologies further enhance the ability to track metal accumulation and distribution in real time. On the therapeutic front, strategies targeting metal dysregulation, such as chelation therapy, metal transporter modulators, and nanocarrier-based drug delivery, are under active investigation. Personalized medicine approaches guided by biomarker profiles are paving the way for tailored inventions. These integrated approaches focus on yearly biomarker-targeted therapy and represent a transformative shift in managing metal-associated neurological disorders with precision and efficacy.

Major health issues like cancer and neurological diseases are caused due to excessive exposure or accumulation of metals like iron, zinc, and copper. The distribution of these elements is regulated by metal homeostasis, which is crucial for maintaining vital cellular functions, including oxygen transport, immune defense, and cellular energy management. The body retains metal homeostasis through mechanisms that control absorption, transport, and storage of these metals. When these regulatory processes malfunction, they give rise to disorders, such as hemochromatosis and Wilson’s disease, which can lead to zinc deficiency. Notably, in neurodegenerative diseases like Alzheimer’s and Parkinson’s, disrupted metal regulation contributes to disease progression through inflammation, oxidative stress, and impaired molecular signalling, all of which aggravate neuronal damage and interfere with neurotransmitter activity. To better understand these mechanisms, researchers use animal models and virtual computer-based models to study how metal imbalance initiates and sustains disease states. Progress in treatment evaluation relies on transitioning from preclinical findings to clinical trials to assess both safety and effectiveness. Recently, computational tools have merged with personalized medicine, using computational software to develop innovative approaches for managing metal-related disorders. These studies focus on tracking biological mechanisms of metals and their links to brain damage, aiming to apply simulation strategies in future research on metal regulation.

Metals are vital to human health, contributing to cellular structure, gene expression, enzymatic functions, neurotransmission, and antioxidant defense. However, dysregulation in metal homeostasis—caused by environmental, occupational, or biological factors—can lead to severe health issues, particularly neurodegenerative disorders like Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease. Essential biometals such as iron, zinc, copper, manganese, magnesium, and calcium are crucial for physiological balance, while their dysregulation is linked to oxidative stress, protein aggregation, and neurodegeneration. Toxic metals like aluminium, cadmium, lead, and mercury further exacerbate these effects by impairing immune and mitochondrial function. Research has increasingly focused on metal transport mechanisms in neurological disorders. Therapeutic interventions include chelating agents to remove excess metals and drugs targeting metal transporters to restore balance. While preclinical models show promise, challenges persist in translating findings to human therapies due to individual variability and disease complexity. Longitudinal studies emphasize the importance of tracking metal exposure over time to better understand disease progression. Preventive and therapeutic strategies also involve dietary regulation and supplementation with essential minerals, along with minimizing exposure to harmful metals, especially in occupational settings. Emerging approaches integrate multi-omics technologies—genomics, proteomics, and metabolomics—to understand the complex role of metals in disease. AI-driven diagnostics and nanomedicine further enhance precision in diagnosis and treatment. This multidisciplinary approach highlights the need for continued research and collaboration to effectively address metal dysregulation and its implications for human health.

Metal imaging techniques are used in various scientific and clinical investigations, which help in the distribution and quantification of metal in biological samples. Different body processes of human beings require essential metals, including magnesium, calcium, iron, manganese, and zinc, but their improper ratios can result in multiple severe health complications, including cancer and metabolic disorders, along with neurodegeneration. This chapter covers the different techniques used for the detection of metals from biological samples, such as Atomic Absorption Spectroscopy (AAS), Inductively Coupled Plasma Mass Spectrometry (ICP-MS), X-ray Fluorescence (XRF), Neutron Activation Analysis (NAA), Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET). The analysis evaluates these techniques based on principles of operation alongside their respective applications, benefits, and downsides in biological and environmental investigations. PET imaging serves three important healthcare fields by implementing metal-based radiotracers, which enhance accuracy in medical imaging processes. The deep-tissue analysis of metal ions becomes possible with MRI systems, although ICP-MS stands out for its ability to analyze biological samples containing trace metals at high speed. This chapter also addresses the various challenges faced by these techniques in the detection of metal from biological samples. This chapter provides a comprehensive study of metal detection methods and their future measurement trends. 

 In today’s fast-moving era of technology and science, nanotechnology has massive potential in treating various neurological disorders, particularly those caused by metals, such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. These disorders are often accompanied by the accumulation or dysregulation of metals (e.g., aluminum, copper, iron, etc.) or metal-based toxic substances in the human brain, which can lead to neurotoxicity and neurodegeneration. The exceptional properties of nanomaterials, such as elevated surface area, improved reactivity, and their ability to traverse biological barriers, make them promising candidates for targeted therapeutic interventions. This chapter investigates the potential applications of nanotechnology in reducing the neurotoxic effects of metals. Here, some feasible future interventions using nanotechnology to provide novel strategies for early-stage diagnosis, personalized treatments, and long-term management of metal-related neurological disorders will be discussed. The incorporation of nanotechnology into clinical practice holds great promise for considerably improving patient outcomes and advancing the field of neurotherapeutics. 

Metal homeostasis plays a critical role in maintaining physiological balance and preventing the onset of various chronic diseases. This chapter highlights the intricate relationship between essential trace metals- iron (Fe), zinc (Zn), and copper (Cu)- and lifestyle factors, including diet, physical activity, stress, sleep, smoking, and alcohol consumption. Disruptions in metal balance, often driven by poor lifestyle choices, have been linked to the development of neurodegenerative disorders, cardiovascular diseases, and cancer. Emerging evidence underscores the role of stressinduced hormonal changes and oxidative stress in metal dysregulation. Interventions such as meditation and exercise have been shown to mitigate oxidative burden, reduce inflammation, and support effective detoxification pathways, particularly through improved liver and kidney function. Furthermore, sleep quality and circadian rhythm synchronization contribute significantly to brain metal detoxification, with melatonin serving as a key neuroprotective agent. This chapter advocated for a holistic, prevention-oriented approach that integrated nutrition, physical activity, stress management, and sleep hygiene to maintain optimal metal homeostasis. Understanding the dynamic interplay between lifestyle behaviors and metal regulation may offer novel therapeutic strategies for managing metal-related pathologies and improving long-term health outcomes. 

Metals play a crucial role in neurological health, but their dysregulation is increasingly linked to neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s. This section explores future research directions focusing on the mechanisms of metal-induced neurotoxicity, including oxidative stress, protein aggregation, and receptor dysregulation. Advanced multi-omics approaches and systems biology are vital for identifying disease-specific metal signatures and therapeutic targets. The development of sensitive diagnostics, such as metal-specific imaging agents and biosensors, can enhance early detection and treatment monitoring. Nanotechnology and targeted drug delivery systems offer promising strategies to modulate metal homeostasis across the blood-brain barrier. Artificial intelligence and personalized medicine are emerging as powerful tools to predict disease progression based on metal exposure and genetic factors. Finally, addressing environmental and occupational exposures through longitudinal studies and regulatory policies remains essential. A multidisciplinary approach is critical to advancing diagnostic therapeutics and prevention strategies in metal-related neurological disorders.